Teva Testosterone Gel Recall: OOS Viscosity Risk
Teva Pharmaceuticals recalls 1.62% testosterone gel with OOS viscosity. This may affect product stability. Consumers should check NDC 0591-2926-30 and lot number 100029472.
Lower-risk recall
OOS for viscosity
Contact the company
What happened, in plain English
Teva Pharmaceuticals is recalling testosterone gel due to viscosity issues that could affect product stability. This recall affects prescription-only products sold in specific packaging. Read more at govinfonow.com/recall/32973-teva-testosterone-gel-recall-oos-viscosity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32973-teva-testosterone-gel-recall-oos-viscosity-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0127-2024
Cite this page
“Teva Testosterone Gel Recall: OOS Viscosity Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32973-teva-testosterone-gel-recall-oos-viscosity-risk. Based on FDA recall #D-0127-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0127-2024%22&limit=1).
Why it’s dangerous
The gel has an out-of-specification viscosity, which may cause the product to separate or become unstable over time. This could affect the medication's effectiveness but does not pose an immediate safety risk.
Who’s affected
Prescription users of Teva's testosterone gel (1.62% CIII) with NDC 0591-2926-30 and lot number 100029472. Patients using this product are most at risk.
How to tell if you have this one
Check for the NDC code 0591-2926-30 and lot number 100029472 on the packaging. This product is sold in 30-unit-dose packets per carton, prescription-only.
- Brand
Teva- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 0591-2926-30 and lot number 100029472 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “USA nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Teva recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0127-2024 (November 10, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0127-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.